Shelley joined Sitryx in May 2019. She has wide-ranging operational, scientific and strategic experience in Biotech drug discovery, life science equities and academic research. Previously Business Operations Manager at Immunocore, she fulfilled a pivotal role in the establishment and growth of the new Infectious Diseases Unit and the development of a portfolio of three programmes towards IND-enablement across multiple sites. Prior to this, Shelley was a public markets Equity Analyst (Biotechnology, Life Science, Technology).
Shelley obtained Bioscience degrees from the University of Oxford (MA, MSc, and DPhil) before completing studies as a Sir Henry Wellcome Postdoctoral Research Fellow in emerging viral disease, molecular bioinformatics and novel sequencing technologies at the Natural History Museum, London. Shelley has published ~30 peer-reviewed papers, multiple first author.